ABCL – abcellera biologics inc. - common shares (US:NASDAQ)
Stock Stats
News
AbCellera Biologics Pivots to Internal Pipeline at JPMorgan, Teases Key Milestones for 2026 [Yahoo! Finance]
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause [Yahoo! Finance]
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at Wall Stree
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at Wall Str
Form 8-K AbCellera Biologics Inc. For: Jan 12
Form 4 AbCellera Biologics Inc. For: Jan 01 Filed by: Booth Andrew
Form 4 AbCellera Biologics Inc. For: Jan 01 Filed by: Hansen Carl L. G.
Form 4 AbCellera Biologics Inc. For: Jan 01 Filed by: Stimart Tryn
Form 4 AbCellera Biologics Inc. For: Jan 01 Filed by: Lecault Veronique
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.